03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Sectral** : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Responsible Party | Sanofi Aventis |
Origin | France |
Manufacturer | Sanofi Aventis |
Origin | Spain |
ATC | C07AB04 |
Sectral** :
Sectral** :
Sectral** :
Sectral** :
Sectral** :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Sectral** :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Antinuclear antibody (ANA) | Very Common |
Bradycardia | Not known |
Bronchospasm | Not known |
Cardiac failure | Not known |
Central nervous system disorder | Not known |
Cold extremities | Not known |
Confusion | Not known |
Cyanosis peripheral | Not known |
Depression | Common |
Diarrhoea (Diarrhea) | Common |
Dry eye | Not known |
Dyspnoea (dyspnea) | Common |
Fatigue | Very Common |
First degree atrioventricular block | Not known |
Gastrointestinal disorders | Very Common |
Hallucination | Not known |
Headache | Common |
Hepatic damage | Not known |
Hepatic enzyme increased | Not known |
Hepatocellular injury | Not known |
Hypotension | Not known |
Intermittent claudication | Not known |
Loss of libido | Not known |
Lung infiltration (pulmonary infiltration) | Not known |
Lupus-like syndrome | Uncommon |
Malaise | Common |
Nausea | Common |
Nightmares | Common |
Paraesthesia (paresthesia) | Not known |
Pneumonia | Not known |
Psychosis | Not known |
Raynaud's phenomenon | Not known |
Skin rash | Common |
Sleep disorder (Sleep disturbance) | Not known |
Visual disturbance | Common |
Vomiting | Not known |
Withdrawal syndrome | Not known |
Sectral** :
NB : Products With Same Indication |
Different Units By MoH Code
Sectral** MoH 5413 :
Form | Tablet, Film-Coated |
Packaging | Blisters |
Package Size | Box of 30 |
Strength | 200mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 23619/06 |
Submission date | 01/01/2006 |
Registration Year | 2009 |
Archived Date | 2018 |
Price Comparison
● Country: | Belgium | |
● Package Size: | 56 | |
● Public Price: | 9.37 EUR | ( 907,728.12 LBP ) |
● Pack size unit used: | 56 | |
● Cost/Unit: | 0,1673 EUR | ( 0.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 27/11/2020 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 56 | |
● Public Price: | 19.18 GBP | ( 2,179,787.82 LBP ) |
● Pack size unit used: | 56 | |
● Cost/Unit: | 0,3425 GBP | ( 0.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | France | |
● Package Size: | 30 | |
● Public Price: | 5.78 EUR | ( 559,943.28 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,1927 EUR | ( 0.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Finland | |
● Package Size: | 100 | |
● Public Price: | 20.36 EUR | ( 1,972,395.36 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,2036 EUR | ( 0.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File